Manufacturer
Bayer Schering Pharma AG
Contents
Recombinant interferon β-1b
Indication
Relapsing-remitting multiple sclerosis, Secondary progressive multiple sclerosis, Single demyelinating event suggestive of multiple sclerosis
Instruction
Inject 1.2 mL of the diluent provided (NaCl 0.54%) into the vial labelled as containing 300 mcg (9.6 MIU) to produce a soln containing 250 mcg/mL (8 MIU). Swirl gently to dissolve.
Drug interaction
May decrease the metabolism of theophylline derivatives, except dyphylline. May decrease the metabolism and enhance the adverse effects of zidovudine.
Malaysia
